May 16, 2016 / 11:27 AM / in 2 years

BRIEF-Revive Therapeutics announces rights offering to fund clinical development of Bucillamine

May 16 (Reuters) - Revive Therapeutics Ltd

* Revive announces rights offering to fund the clinical development of Bucillamine for the treatment of Cystinuria Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below